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ABSTRACT – Background and Objectives: Testosterone deficiency has been implicated
in the etiology of depression although there is an ongoing debate on the nature of this
association. There is a paucity of data about the psychological impact of hypogonadism in
genetic disorders associated with testosterone deficiency.
Methods: A 57-year-old male is described who was referred for treatment resistant
depression. His history showed infertility and lowered testosterone. A selective literature
review is given to clarify the patient’s clinical condition.
Results: Cytogenetic analysis demonstrated a Robertsonian translocation between
chromosomes 13 and 14 that accounted for his infertility. The psychopathological picture
did not meet the criteria for a major depressive disorder but was characterized by symp-
toms of apathy or avolition. These symptoms were most probably aggravated by previous
long lasting treatment with antidepressants. 
Conclusions: Testosterone deficiency may be related to motivational deficits that
should not be misunderstood for depressive illness. Apathy is probably an underestimated
side effect of antidepressants.
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Introduction
In the sixties and seventies of the past cen-
tury many studies have examined the chromo-
somal contribution to male infertility. Report-
ed frequencies of chromosomal abnormalities
range from 2.2% to 19.6% depending on the
severity of male infertility1. Since the intro-
duction of modern in vitro fertilization tech-
niques, it is common practice to perform
cytogenetic screening in patients with male
infertility and chromosomal anomalies in up
to 12% of cases are found of which the
Robertsonian translocation 13;14 is the most
frequent2-4. The majority of infertile males
have normal levels of testosterone, LH and
FSH. There is only one older case report
about a slightly lower testosterone in a
patient with this type of translocation5. In
some infertile patients a primary testicular
failure is present in which only low testos-
terone levels are found6.
It is well known that androgens like testos-
terone are implicated not only in sexual func-
tions, but are thought to be also involved in
aggression, social ranking and mood,
although the data are difficult to interpret7,8.
With respect to mood, it is hypothesized that
testosterone modulates the activity of the
hypothalamic pituitary adrenal axis9. Most
studies about the relationship between mood
and testosterone have been performed in
aging men. It is still unclear whether there is a
relationship between lower testosterone and
major depression. Psychological dysfunctions
such as irritability, fatigue, decreased sex
drive, lack of motivation, and energy and a
reduced feeling of well being are found that
do not meet the criteria for a categorical diag-
nosis of major depression with or without
melancholia10-13.
In male patients with oligozoospermia
and testosterone deficiency caused by a
cytogenetic abnormality, hypogonadism is
life long present and therefore the psycho-
logical consequences of low testosterone
can be hypothesized to have a major impact
on the development as a whole. Reports
about hypogonadism with a genetic cause
on development and psychological func-
tioning are lacking.
In this case report, a male patient is
described who had been treated for a depres-
sive illness during several decades and in
whom infertility due to a genetic abnormali-
ty and low testosterone was demonstrated.
These findings are discussed in relation to
the testosterone-depression debate. 
Case report
The patient is a 57 year old male who was
referred to the department of neuropsychiatry
for re-evaluation of long lasting therapy
resistant mood disturbances. He was born
from non consanguine parents and had 3
younger sibs. His family history showed no
mental disorders. During infancy and devel-
opment there were no major somatic prob-
lems. His developmental history was charac-
terized by a certain social withdrawal and
lack of motivation in all domains. Although
the patient completed both elementary and
high school, his professional career showed a
plethora of unfinished educations and non
demanding jobs. From the age of 22 there
were complaints about feelings of inferiority,
mood instability and problems in task com-
pletion for which he visited several psycholo-
gists and psychiatrists. In subsequent years
the patient had several short lasting relation-
ships and sexual dysfunctions. He married
aged 37 and he has a 12 years old son. At the
age of 51 he was declared unable to work.
Two years before, a diagnosis of bipolar
affective disorder was made elsewhere for
which he was treated with carbamazepine,
Lithium and citalopram. During subsequent
years treatment with various combinations of
mood stabilizers and antidepressants did not
improve his daily functioning and mood
symptoms. The last 3 years his daily treat-
ment consisted of 1500mg Lithium (0.9
mmol/l) and 1350mg (67mg/l) valproic acid.
Six years ago he developed obesity and
insuline dependent diabetes mellitus type II,
complicated by neuropathy that was con-
firmed with electromyography as well as an
increased erectile dysfunction. Sildenafil was
ineffective. Because of a low free testos-
terone (4.4 nmol/l; normal range: 10-28
nmol/l) and increased levels of LH (13,1 U/l;
normal range: 2-9 U/l) and FSH (27,9 U/l;
normal range:1,5-12 U/l), three years later a
diagnosis of hypogonadism was made for
which he was treated with testosterone once
biweekly for 3 months without any effect on
erectile function or general well being. For
his diabetes mellitus the patient used insulin
and oral antidiabetics.
At admission, the patient complained
about fatigue, irritability, loss of libido,
erectile dysfunction, problems in task com-
pletion and the inability to lead a self-serv-
ing life. He presented with a submissive and
passive attitude, mental slowness and tired-
ness. Neuropsychiatric examination by means
of a semi structured interview using the ele-
ments of the Comprehensive Psychiatric
Rating Scale disclosed no major psychiatric
disorder. Anamnestic information revealed
infertility and his son was born after donor
insemination. Extensive neuropsychological
assessment demonstrated a total IQ of 128
(WAIS-III; verbal: 122; performal: 127), a
mild to moderate impairment of attention/con-
centration with subsequent problems in the
area of executive functioning. These mild
cognitive dysfunctions were found to be
embedded in a personality pattern charac-
terized by self-devaluation combined with
heightened sensitivity for critical evaluation,
experiential avoidance, and low persistence.
Somatic examination showed, apart from a
BMI of 35 (length: 1.82m; weight: 115kg;
waist circumference: 120cm), no abnormali-
ties and normal genitals. Laboratory data
showed slightly increased values for glucose
and HbA1c and a testosterone level at the
lower margin of the reference values (11,0
nmol/l; normal range: 9-38 nmol/l). Because
of his infertility, cytogenetic analysis was
performed that demonstrated a Robertsonian
translocation between the chromosomes 13
and 14 (figure 1) [karyotype: 45,XY, der
(13;14) (q10;q10)].
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Figure 1. Robertsonian translocation 45,XYder(13;14)(q10;q10).
During the clinical observation period,
mood stabilizing agents were gradually
tapered off and his medication for the dia-
betes mellitus was optimalized. At dis-
charge the patient used insulin and oral
antidiabetics and he reported an increased
level of activity and feeling of well being. 
Because of complete impotence, he under-
went, after discharge, a second treatment
with testosterone for 3 months that, however,
was ineffective. At follow up after one year,
the daily functioning of the patient was still
characterized by lower psychological vitali-
ty, lack of motivation and irritability.
Discussion
In the here reported patient, referred for
treatment refractory depression, cytogenetic
analysis demonstrated a Robertsonian
translocation between chromosomes 13 and
14 associated with infertility due to oligo-
zoospermia. His medical history mentioned
a testosterone deficiency, possibly related to
the cytogenetic abnormality and aggravated
by the diabetes mellitus type II. After dis-
continuation of all psychotropics, his daily
functioning improved and returned to the
level he had before the prescription of anti-
depressants and mood stabilizers. A second
trial with testosterone did not improve his
erectile dysfunction neither his psychologi-
cal functioning. In retrospect, his obesity
was aggravated by the use of antidepressants
and mood stabilizers that resulted in insuline
resistance and diabetes mellitus. Moreover,
his avolition and apathy increased due to
treatment with antidepressants and conse-
quently he was declared unable to work at
the age of 51. It cannot be ruled out that his
low testosterone levels have caused reduced
insulin sensitivity14.
Based on his history and the assessment of
psychopathology and psychological function-
ing, a diagnosis of depressive disorder could
not be established. In fact, his clinical condi-
tion could better be accounted for by the term
‘apathy’ or by the ‘syndrome of avolition’. The
syndrome of apathy comprises lack of motiva-
tion, diminished goal-directed cognition and
reduced emotional concomitance of goal-
directed behaviour15,16. It is often characterized
by life long passivity, low role activity, low self
esteem and low life satisfaction. Avolition is a
psychological state characterized by severe
problems in willed action, typically presenting
with a general lack of desire, drive or motiva-
tion to strive for meaningful goals, and related
to executive dysfunctioning. Symptoms of apa-
thy or dysexecutive functioning can be induced
or enhanced by antidepressants, especially
SSRI’s, and are reported in case series with
children and adults17,18. In the epidemiological
study by Van Geffen and coworkers, this phe-
nomenon is listed as one of the 15 most fre-
quently side effects reported by patients19.
Since the isolation of testosterone in the
early thirties of the past century, this androgen
has been associated with mood disturbances
and subsequently used in the treatment of
‘depression’20. During the past decades, sever-
al placebo-controlled clinical trials with testos-
terone have been performed in hypogonadal
older men, demonstrating antidepressant like
effects in some but not all studies21. It should
be stressed, however, that these studies deal
with mild depression and that the effects are
only minimal. This can be illustrated by the
study by Pope and coworkers who reported an
antidepressant effect that was restricted to the
non-affective symptoms of the Hamilton
Depression Rating Scale but not present on the
Beck Depression Inventory22. The effects of
testosterone may therefore reflect the reversal
of age related fatigue instead of a direct effect
of this androgen on depression23. As stated by
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Amore, the relationship between testosterone
deficiency and psychological dysfunctions
may be the result of an interaction between
biological and social changes and of the per-
sonal ability to adapt to age-related changes12.
In conclusion, symptoms of avolition and
apathy are clinically relevant in hypogonadal
men and should not be automatically placed in
the expanding categorical concept of depres-
sion. Since such symptoms can be worsened by
antidepressants, especially SSRI’s, clinicians
should be cautious in the prescription of these
compounds, particularly in hypogonadal men. 
References
1. Chandley AC. The chromosomal basis of human
infertility. Br Med Bull 1979; 35: 181-186.
2. Mau UA, Bäckert IT, Kaiser P, et al. Chromosomal
findings in 150 couples referred for genetic counselling
prior to intracytoplasmic sperm injection. Hum Reprod
1997; 12: 930-937.
3. Tuerlings JHAM, De France HF, Hamers A, et al.
Chromosome studies in 1792 males prior to intracytoplas-
mic sperm injection: the Dutch experience. Eur J Hum
Genet 1998; 6: 194-200.
4. Peschka B, Leygraag J, Van der Ven K, et al. Type and
frequency of chromosome aberrations in 781 couples
undergoing intracytoplasmic sperm injection. Hum Reprod
1999; 9: 2257-2263.
5. Uccellatore F, Padova G, Squatrito S. Reproductive
hormone studies in three subjects with a Robertsonian
translocation. J Endocrinol Invest 1983; 6: 479-484.
6. Bhasin S. Approach to the patient. Approach to the
infertile man. J Clin Endocrinol Metab 1995; 92: 1995-2004.
7. Rubinow DR, Schmidt PJ. Androgens, brain, and
behavior. Am J Psychiatry 1996; 153: 974-984.
8. Mazur A, Booth A. Testosterone and dominance in
men. Behav Brain Sci 1998; 21: 353-397.
9. Rubinow DR, Roca CA, Schmidt PJ et al. Testosterone
suppression of CRH-stimulated cortisol in men. Neuropsy-
chopharmacology 2005; 30: 1906-1912.
10. Delhez M, Hansenne M, Legros JJ. Andropause and
psychopathology: minor symptoms rather than pathologi-
cal ones. Psychoneuroendocrinology 2003; 28: 863-874.
11. Shores MM, Moceri VM, Sloan KL, et al. Low tes-
tosterone levels predict incident depressive illness in older
men: effects of age and medical morbidity. J Clin Psy-
chiatry 2005; 66: 7-14
12. Amore M. Partial androgen deficiency and neuropsy-
chiatric symptoms in aging men. J Endrocrinol Invest 2005;
28: 49-54.
13. Tostain JL, Blanc F. Testosterone deficiency: a com-
mon, unrecognized syndrome. Nat Clin Pract Urol 2008; 5:
388-396. 
14. Kapoor D, Aldred H, Clark S, et al. Clinical and bio-
chemical assessment of hypogonadism in men with type 2
diabetes. Diabetes Care 2007; 30: 911-917.
15. Marin RS. Differential diagnosis and classification
of apathy. Am J Psychiatry 1990; 147: 22-30.
16. Marin RS. Apathy: a neuropsychiatric syndrome. J
Neuropsychiatry Clin Neurosci 1991; 3: 243-253.
17. Hoehn-Saric R, Lipsey JR, McLeod DR. Apathy and
indifference in patients on fluvoxamine and fluoxetine. J
Clin Psychopharmacol 1990; 10: 343-345.
18. Garland EJ, Baerg EA. Amotivational syndrome
associated with selective serotonin reuptake inhibitors in
children and adolescents. Child Adolesc Psychopharmacol
2001; 11: 181-186.
19. Van Geffen ECG, Van der Wal SW, Van Hulten R, et
al. Evaluation of patients’ experiences with antidepressants
reported by means of a medicine reporting system. Eur J
Clin Pharmacol 2007; 63: 1193-1199.
20. Danziger L, Blank HR. Androgen therapy of agitated
depressions in the male. Med Ann DC 1942; 1: 181-183.
21. Carnahan RM, Perry PJ. Depression in aging men.
Drugs Aging 2004; 21: 361-376.
22. Pope HG, Cohane GH, Kanayama G, et al. Testoste-
rone gel supplementation for men with refractory depres-
sion: a randomized, placebo-controlled trial. Am J Psy-
chiatry 2003; 160: 105-111.
23. Schmidt PJ, Berlin KL, Danaceau MA, et al. The effects
of pharmacologically induced hypogonadism on mood in
healthy men. Arch Gen Psychiatry 2004; 61: 997-1004.
Address for correspondence:
Prof. Dr. W.M.A. Verhoeven
Vincent van Gogh Institute for Psychiatry
Stationsweg 46
5803AC Venray, The Netherlands 
Phone: 0031.478527339
Fax: 0031.478527339
E-mail: wverhoeven@vvgi.nl
AVOLITION AND HYPOGONADISM 199
